New insights into homopiperazine-based 5-HT_1A/5-HT₇R ligands: synthesis and biological evaluation

References

• Ruat M, Traiffort E, Leurs R, Tardivel-Lacombe J, Diaz J, Arrang JM, et al. Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc Natl Acad Sci USA 1993;90:8547–51.
   PubMed Web of Science ®Google Scholar
• Bard JA, Zgombick J, Adham N, Vaysse P, Branchek TA, Weinshank RL. Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J Biol Chem 1993;268:23422–6.
   PubMed Web of Science ®Google Scholar
• Lovenberg TW, Baron BM, de Lecea L, Miller JD, Prosser RA, Rea MA, et al. A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron 1993;11:449–58.
   PubMed Web of Science ®Google Scholar
• Thomas DR, Hagan JJ. 5-HT7 receptors. Curr Drug Targets CNS Neurol Disord 2004;3:81–90.
   PubMedGoogle Scholar
• Hedlund PB, Sutcliffe JG. Functional, molecular and pharmacological advances in 5-HT7 receptor research. Trends Pharmacol Sci 2004;25:481–6.
   PubMed Web of Science ®Google Scholar
• Pittala V, Salerno L, Modica M, Siracusa MA, Romeo G. 5-HT7 receptor ligands: recent developments and potential therapeutic applications. Mini Rev Med Chem 2007;7:945–60.
   PubMed Web of Science ®Google Scholar
• Mnie-Filali O, Lambas-Senas L, Zimmer L, Haddjeri N. 5-HT7 receptor antagonists as a new class of antidepressants. Drug News Perspect 2007;20:613–18.
   PubMed Web of Science ®Google Scholar
• Cifariello A, Pompili A, Gasbarri A. 5-HT(7) receptors in the modulation of cognitive processes. Behav Brain Res 2008;195:171–9.
   PubMed Web of Science ®Google Scholar
• Lopez-Rodriguez ML, Benhamu B, Morcillo MJ, Porras E, Lavandera JL, Pardo L. Serotonin 5-HT7 receptor antagonists. Curr Med Chem CNS Agents 2004;4:203–14.
   Google Scholar
• Leopoldo M. Serotonin(7) receptors (5-HT(7)Rs) and their ligands. Curr Med Chem 2004;11:629–61.
   PubMed Web of Science ®Google Scholar
• Shireman BT, Bonaventure P, Carruthers NI, John EM. Recent advances on the 5-HT5A, 5-HT6 and 5-HT7 receptors. Annu Rep Med Chem 2008;43:25–42.
   Web of Science ®Google Scholar
• Forbes IT, Douglas S, Gribble AD, Ife RJ, Lightfoot AP, Garner AE, et al. SB-656104-A: a novel 5-HT7 receptor antagonist with improved in vivo properties. Bioorg Med Chem Lett 2002;12:3341–4.
   PubMed Web of Science ®Google Scholar
• Kikuchi C, Nagaso H, Hiranuma T, Koyama M. Tetrahydrobenzindoles: selective antagonists of the 5-HT7 receptor. J Med Chem 1999;42:533–5.
   PubMed Web of Science ®Google Scholar
• Holmberg P, Sohn D, Leideborg R, Caldirola P, Zlatoidsky P, Hanson S, et al. Novel 2-aminotetralin and 3-aminochroman derivatives as selective serotonin 5-HT7 receptor agonists and antagonists. J Med Chem 2004;47:3927–30.
   PubMed Web of Science ®Google Scholar
• Bojarski AJ. Pharmacophore models for metabotropic 5-HT receptor ligands. Curr Top Med Chem 2006;6:2005–26.
   PubMed Web of Science ®Google Scholar
• Isaac MB, Xin T, O’Brien A, St-Martin D, Naismith A, MacLean N, et al. 1-(Bicyclopiperazinyl)ethylindoles and 1-(homopiperazinyl)ethyl-indoles as highly selective and potent 5-HT7 receptor ligands. Bioorg Med Chem Lett 2002;12:2451–4.
   PubMed Web of Science ®Google Scholar
• Miranda LD, Cruz-Almanza R, Pavón M, Alva E, Muchowski JM. A tandem carbonylation/cyclization radical process of 1-(2-iodoethyl)indoles and pyrrole. Tetrahedron Lett 1999;40:7153–7.
   Web of Science ®Google Scholar
• Zhang Z, Yang Z, Meanwell NA, Kadow JF, Wang T. A general method for the preparation of 4- and 6-azaindoles. J Org Chem 2002;67:2345–7.
   PubMed Web of Science ®Google Scholar
• Joseph B, Benarab A, Guillaumet G. Synthesis of N-substituted 3-aminomethyl-2,3-dihydrofuro[2,3-c]pyridines, potent serotoninergic ligands. Heterocycles 1995;41:2769–76.
   Web of Science ®Google Scholar
• Paluchowska MH, Bugno R, Duszynska B, Tatarczynska E, Nikiforuk A, Lenda T, Chojnacka-Wojcik E. The influence of modifications in imide fragment structure on 5-HT(1A) and 5-HT(7) receptor affinity and in vivo pharmacological properties of some new 1-(m-trifluoromethylphenyl)piperazines. Bioorg Med Chem 2007;15:7116–25.
   PubMed Web of Science ®Google Scholar
• Thomson CG, Beer MS, Curtis NR, Diggle HJ, Handford E, Kulagowski JJ. Thiazoles and thiopyridines: novel series of high affinity h5HT(7) ligands. Bioorg Med Chem Lett 2004;14:677–80.
   PubMed Web of Science ®Google Scholar
• Wang T, Zhang Z, Wallace OB, Deshpande M, Fang H, Yang Z, et al. Discovery of 4-Benzoyl-1-[(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2-(R)-methylpiperazine (BMS-378806): a novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions. J Med Chem 2003;46:4236–9.
   PubMed Web of Science ®Google Scholar
• Schneller SW, Luo J-K. Synthesis of 4-amino-1H-pyrrolo[2,3-b]pyridine (1,7-dideazaadenine) and 1H-pyrrolo[2,3-b]pyridin-4-ol (1,7-dideazahypoxanthine). J Org Chem 1980;45:4045–8.
   Web of Science ®Google Scholar
• Minakata S, Komatsu M, Ohshiro Y. Regioselective functionalization of 1h-pyrrolo[2,3-b]pyridine via its N-oxide. Synthesis 1992;(07): 661–3.
   Google Scholar